摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-(4-(benzyloxy)-5-methoxy-2-nitrophenyl)(3-(hydroxymethyl)-3,4-dihydroisoquinolin-2(1H)-yl)methanone | 762245-27-2

中文名称
——
中文别名
——
英文名称
(S)-(4-(benzyloxy)-5-methoxy-2-nitrophenyl)(3-(hydroxymethyl)-3,4-dihydroisoquinolin-2(1H)-yl)methanone
英文别名
[(3S)-3-(hydroxymethyl)-3,4-dihydro-1H-isoquinolin-2-yl]-(5-methoxy-2-nitro-4-phenylmethoxyphenyl)methanone
(S)-(4-(benzyloxy)-5-methoxy-2-nitrophenyl)(3-(hydroxymethyl)-3,4-dihydroisoquinolin-2(1H)-yl)methanone化学式
CAS
762245-27-2
化学式
C25H24N2O6
mdl
——
分子量
448.475
InChiKey
RWTVVRYBJODJAZ-FQEVSTJZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    33
  • 可旋转键数:
    6
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.24
  • 拓扑面积:
    105
  • 氢给体数:
    1
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] POLYCYCLIC AMIDES AS CYTOTOXIC AGENTS<br/>[FR] AMIDES POLYCYCLIQUES SERVANT D'AGENTS CYTOTOXIQUES
    申请人:FEMTOGENIX LTD
    公开号:WO2020049286A1
    公开(公告)日:2020-03-12
    The invention relates to a compound of formula (I): or pharmaceutically acceptable salts, solvates, tautomers, stereoisomers or mixtures thereof; wherein the fused ring moiety is a non-alkylating moiety; and wherein the compounds are useful as medicaments, in particular for use as a drug in an antibody-drug conjugate and in the treatment of a proliferative disease, a bacterial infection, a malarial infection and inflammation.
    该发明涉及公式(I)的化合物;或其药学上可接受的盐、溶剂合物、互变异构体、立体异构体或它们的混合物;其中融合环基团是非烷基化基团;这些化合物可用作药物,特别是用作抗体药物结合物中的药物,以及用于治疗增殖性疾病、细菌感染、疟疾感染和炎症。
  • [EN] CYTOTOXIC AGENTS<br/>[FR] AGENTS CYTOTOXIQUES
    申请人:FEMTOGENIX LTD
    公开号:WO2019043417A1
    公开(公告)日:2019-03-07
    The invention relates to a compound of formula (I) or formula (II) or pharmaceutically acceptable salts, solvates, tautomers, stereoisomers or mixtures thereof; which are useful as medicaments, in particular as anti-proliferative agents and for use as a drug in an antibody-drug conjugate and in the treatment of proliferative diseases.
    该发明涉及公式(I)或公式(II)的化合物,或其药学上可接受的盐、溶剂合物、互变异构体、立体异构体或其混合物;这些化合物可用作药物,特别是作为抗增殖剂,并用作抗体-药物结合物中的药物,用于治疗增殖性疾病。
  • [EN] BENZODIAZEPINE DERIVATIVES<br/>[FR] DÉRIVÉS DE BENZODIAZÉPINE
    申请人:IMMUNOGEN INC
    公开号:WO2019133652A1
    公开(公告)日:2019-07-04
    The invention relates to novel benzodiazepine derivatives with antiproliferative activity and more specifically to novel benzodiazepine compounds of formulae (I), (II) and (III). The invention also provides conjugates of the benzodiazepine compounds linked to a cell-binding agent. The invention further provides compositions and methods useful for inhibiting abnormal cell growth or treating a proliferative disorder in a mammal using the compounds or conjugates of the invention.
    该发明涉及具有抗增殖活性的新型苯二氮卓衍生物,更具体地涉及具有公式(I)、(II)和(III)的新型苯二氮卓化合物。该发明还提供了与细胞结合剂连接的苯二氮卓化合物的结合物。此外,该发明还提供了使用该发明的化合物或结合物抑制异常细胞生长或治疗哺乳动物增殖性疾病的有效组合物和方法。
  • [EN] ASYMMETRIC CONJUGATE COMPOUNDS<br/>[FR] COMPOSÉS CONJUGUÉS ASYMÉTRIQUES
    申请人:FEMTOGENIX LTD
    公开号:WO2017194960A1
    公开(公告)日:2017-11-16
    The invention relates to compound of formula (I): A-X1-L-X2-B and salts, solvates and tautomers thereof, which are useful as medicaments, in particular as anti-proliferative agents and for use as a drug in an antibody-drug conjugate; wherein A is a group selected from (A1), (A2), (A3), (A4) and (A5); X1 and X2 are independently selected from O, S, NR28, CR28R29, CR28R29O, C(=O), C(=O)NR28, NR28C(=O), C(O)-RA-C(O)-NH, C(O)-RA-NH-C(O), C(O) -NH-RA-C(O), NH-C(O)-RA-C(O), NH-C(O)-RA-C(O)-NH, NH-C(O)-RA-NH-C(O), C(O)-NH-RA-NH-C(O), C(O)-NH-RA-C(O)-NH, O-C(O) and C(O)-O or is absent; L is selected from an amino acid, a peptide chain having from 2 to 12 amino acids, a paraformaldehyde chain –(OCH2)1-24-, a polyethylene glycol chain -(OCH2CH2)1-12- and –(CH2)m-Y6-(CH2)n- wherein Y6 is selected from –(CH2)z- and a group (L1) a group (L1) that is selected from arylene, monocyclic heteroarylene, monocyclic cycloalkylene, monocyclic cycloalkenylene and monocyclic heterocyclylene groups optionally substituted with up to three optional substituent groups; and B is a polycyclic group selected from (B1), (B2) and (B3).
    该发明涉及化合物的公式(I):A-X1-L-X2-B及其盐、溶剂合物和互变异构体,其作为药物具有实用性,特别是作为抗增殖剂并用作抗体药物结合物中的药物;其中A是从(A1)、(A2)、(A3)、(A4)和(A5)中选择的基团;X1和X2分别选择自O、S、NR28、CR28R29、CR28R29O、C(=O)、C(=O)NR28、NR28C(=O)、C(O)-RA-C(O)-NH、C(O)-RA-NH-C(O)、C(O)-NH-RA-C(O)、NH-C(O)-RA-C(O)、NH-C(O)-RA-C(O)-NH、NH-C(O)-RA-NH-C(O)、C(O)-NH-RA-NH-C(O)、C(O)-NH-RA-C(O)-NH、O-C(O)和C(O)-O或者不存在;L选择自氨基酸、具有2至12个氨基酸的肽链、对甲醛链-(O )1-24-、聚乙二醇链-(O )1-12-和-(CH2)m-Y6-( )n-,其中Y6选择自-( )z-和一个基团(L1),该基团(L1)选择自芳基、单环杂芳基、单环环烷基、单环环烯烃基和单环杂环烷基,可选地取代高达三个可选取代基团;B是从(B1)、(B2)和(B3)中选择的多环基团。
  • [EN] CYTOTOXIC BENZODIAZEPINE DERIVATIVES AND CONJUGATES THEREOF<br/>[FR] DÉRIVÉS DE BENZODIAZÉPINE CYTOTOXIQUES ET LEURS CONJUGUÉS
    申请人:IMMUNOGEN INC
    公开号:WO2018195243A1
    公开(公告)日:2018-10-25
    The invention relates to novel benzodiazepine derivatives with antiproliferative activity and more specifically to novel benzodiazepine compounds of formulae (I) and (II). The invention also provides conjugates of the benzodiazepine compounds linked to a cell-binding agent. The invention further provides compositions and methods useful for inhibiting abnormal cell growth or treating a proliferative disorder in a mammal using the compounds or conjugates of the invention.
    该发明涉及具有抗增殖活性的新型苯二氮䓬啶衍生物,更具体地涉及具有化学式(I)和(II)的新型苯二氮䓬啶化合物。该发明还提供了将苯二氮䓬啶化合物与细胞结合剂结合的共轭物。该发明还提供了使用该发明的化合物或共轭物抑制异常细胞生长或治疗哺乳动物增殖性疾病的组合物和方法。
查看更多